<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04311099</url>
  </required_header>
  <id_info>
    <org_study_id>OPMICS-1</org_study_id>
    <nct_id>NCT04311099</nct_id>
  </id_info>
  <brief_title>Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery</brief_title>
  <acronym>OPMICS</acronym>
  <official_title>Laparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block in Minimally Invasive Colon Surgery: A Randomized Controlled Multicentre Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Claus Anders Bertelsen, PhD, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nordsjaellands Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the trial is to identify the &quot;most simple non-inferior of three different
      methods&quot;, placebo, laparoscopic assisted transverse abdominal plane block (L-TAP) and
      ultrasound guided TAP block (US-TAP), using postoperative opioid consumption as a measure of
      efficacy in patients undergoing elective minimally invasive colon surgery in an ERAS setting.
      Postoperative pain scores and length of stay (LOS) will also be measured. The simplicity of
      the three methods is ranked as: 1) placebo, 2) L-TAP and 3) US-TAP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introducing laparoscopy in colorectal surgery and optimizing the postoperative care using the
      standardized protocols of enhanced recovery after surgery (ERAS) have significantly improved
      patient outcomes and LOS. Better pain management has the potential to further improve these
      outcomes. Since the introduction of ultrasound-guided abdominal wall blocks, much research
      has been done in that field, but no consensus has been reached concerning the optimal block
      technique; where to and when to inject the block, or which drug to use. Newly published
      randomized controlled trials show interesting results regarding the L-TAP which has several
      advantages to the US-TAP, including the ease of performance, less dependency on specialized
      skills or equipment and avoidance of intraperitoneal infiltration. but these results need to
      be solidified with multicentre trials. Besides optimizing postoperative pain management,
      better block techniques could potentially decrease LOS in patients after minimally invasive
      colorectal surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total morphine dose equivalents administered.</measure>
    <time_frame>The first 24 hours from the end of anesthesia.</time_frame>
    <description>Intravenously in milligrams.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total morphine dose equivalents administered in the operation theater.</measure>
    <time_frame>Up to 12 hours.</time_frame>
    <description>Intravenously in milligrams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total morphine dose equivalents administered in the post anesthesia care unit.</measure>
    <time_frame>The first 24 hours from the end of anesthesia.</time_frame>
    <description>Intravenously in milligrams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain at rest - 8:00-10:00 AM (ante meridiem) Postoperative Day 1.</measure>
    <time_frame>Postoperative Day 1.</time_frame>
    <description>11-point Numeric Rating Scale. 0-10 (higher score - worse outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain when coughing - 8:00-10:00 AM Postoperative Day 1</measure>
    <time_frame>Postoperative Day 1.</time_frame>
    <description>11-point Numeric Rating Scale. 0-10 (higher score means worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative length of stay.</measure>
    <time_frame>Up to 30 days.</time_frame>
    <description>Days - Measured from the end of anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Postoperative Nausea and Vomiting - 8:00-10:00 AM Postoperative Day 1.</measure>
    <time_frame>Postoperative Day 1.</time_frame>
    <description>4-point Numeric Rating Scale. 0-3 (higher score means worse outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of antiemetic medication administered.</measure>
    <time_frame>In the first 24 hours from the end of anesthesia.</time_frame>
    <description>Intravenously in milligrams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of antiemetic medication administered in the operating theater.</measure>
    <time_frame>Up to 12 hours.</time_frame>
    <description>Intravenously in milligrams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in the post anesthesia care unit.</measure>
    <time_frame>Up to 30 hours.</time_frame>
    <description>From the end of anesthesia to discharge to ward. Measured in hours and minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative mobilisation.</measure>
    <time_frame>Postoperative Day 1.</time_frame>
    <description>4-point Verbal Rating Scale. 1-4 (higher score means worse outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery 15.</measure>
    <time_frame>Postoperative Day 1.</time_frame>
    <description>The Quality of Recovery 15 is a 15-item questionnaire that measures the patient's quality of recovery. Each item is answered on an 11-point Numerical Rating Scale. The score ranges from 0 to 150 with a higher score indicating a better quality of recovery. It measures in the domains of pain, physical comfort, physical independence, psychological support, and emotional state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications.</measure>
    <time_frame>Postoperative Day 30.</time_frame>
    <description>According to the Clavien-Dindo classification of surgical complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for rescue TAP-block or epidural analgesia.</measure>
    <time_frame>Postoperative Day 30.</time_frame>
    <description>Epidural or TAP-block administered post surgery.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Pain, Abdominal</condition>
  <condition>Analgesia</condition>
  <condition>Surgery</condition>
  <condition>Colon Cancer</condition>
  <condition>Injection Site</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided TAP with 20 ml ropivacaine 2 mg/ml solution bilaterally and laparoscopic assisted injection of 20 ml saline (placebo) bilaterally at the beginning of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic assisted TAP with 20 ml ropivacaine 2 mg/ml solution bilaterally and ultrasound-guided injection of 20 ml saline (placebo) bilaterally at the beginning of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Laparoscopic assisted injection of 20 ml saline (placebo) bilaterally and ultrasound-guided injection of 20 ml saline (placebo) bilaterally at the beginning of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Injection of Ropivacaine</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Injection of Saline solution</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guided transverse abdominal plane block</intervention_name>
    <description>Injection of Ropivacaine - Ultrasound-guided transverse abdominal plane block</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic assisted transverse abdominal plane block</intervention_name>
    <description>Injection of Ropivacaine - Laparoscopic assisted transverse abdominal plane block</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guided transverse abdominal plane block</intervention_name>
    <description>Injection of placebo - Ultrasound-guided transverse abdominal plane block</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic assisted transverse abdominal plane block</intervention_name>
    <description>Injection of placebo - Laparoscopic assisted transverse abdominal plane block</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients planned to receive curative elective minimally invasive colon surgery for
             colon cancer or adenoma without a planned ostomy. Colon cancer or adenoma is defined
             by a distance of more than 15 cm from the anal verge to the distal limitation of the
             tumour or adenoma as measured by rigid sigmoidoscope. The following procedural codes
             are included:

          -  Laparoscopic ileocecal resection

          -  Laparoscopic right hemicolectomy

          -  Other laparoscopic resection of both small and large bowel

          -  Laparoscopic resection of transverse colon

          -  Laparoscopic left hemicolectomy

          -  Laparoscopic resection of sigmoid colon

          -  Other laparoscopic colon resection

          -  Having given informed written consent.

        Exclusion Criteria:

          -  Known allergy to local analgesics

          -  Known liver failure Class C according to the Child-Pugh Score

          -  Body weight of less than 40 kg

          -  History of being a chronic pain patient (weekly intake WHO step II or step III or
             adjuvant step I analgesic)

          -  Presence of concomitant painful conditions other than low back pain that could
             confound the subject's trial assessments or self-evaluation of the index pain, e.g.,
             syndromes with widespread pain such as fibromyalgia

          -  Predictably non-compliant due to language barrier or psychiatric disease

          -  Patients rescheduled for open surgery, before the intervention has been administered

          -  Patients where the indication for surgery changes before the intervention has been
             administered

          -  Patients with known inflammatory bowel disease

          -  Patients who have previously undergone open major abdominal surgery defined by prior
             intraabdominal surgery with a midline or upper abdominal incision of more than 8 cm

          -  Incisional hernia

          -  Patients with a history of abdominal wall surgery including resection of the external
             oblique muscles, the internal oblique muscles, the transversus abdominis muscles, the
             rectus abdominis muscles or their fascial components

          -  Pregnancy (patients are screened using urine human chorionic gonadotropin upon
             admission if female and not postmenopausal).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claus A Bertelsen, PhD</last_name>
    <phone>+4551906303</phone>
    <email>cabertelsen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christopher B Salmonsen, MD</last_name>
    <phone>+4523373025</phone>
    <email>chrisbsal@gmail.com</email>
  </overall_contact_backup>
  <link>
    <url>http://www.who.int/ncds/management/palliative-care/cancer-pain-guidelines/en/</url>
    <description>World Health Organization (WHO) guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents.</description>
  </link>
  <link>
    <url>https://www.dsth.dk/bridging2018/</url>
    <description>Pausing or bridging patients in antithrombotic therapy, which should undergo an operative intervention.</description>
  </link>
  <reference>
    <citation>Helander EM, Webb MP, Bias M, Whang EE, Kaye AD, Urman RD. A Comparison of Multimodal Analgesic Approaches in Institutional Enhanced Recovery After Surgery Protocols for Colorectal Surgery: Pharmacological Agents. J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):903-908. doi: 10.1089/lap.2017.0338. Epub 2017 Jul 25.</citation>
    <PMID>28742427</PMID>
  </reference>
  <reference>
    <citation>Grant MC, Yang D, Wu CL, Makary MA, Wick EC. Impact of Enhanced Recovery After Surgery and Fast Track Surgery Pathways on Healthcare-associated Infections: Results From a Systematic Review and Meta-analysis. Ann Surg. 2017 Jan;265(1):68-79. doi: 10.1097/SLA.0000000000001703. Review. Erratum in: Ann Surg. 2017 Dec;266(6):e123.</citation>
    <PMID>28009729</PMID>
  </reference>
  <reference>
    <citation>Johns N, O'Neill S, Ventham NT, Barron F, Brady RR, Daniel T. Clinical effectiveness of transversus abdominis plane (TAP) block in abdominal surgery: a systematic review and meta-analysis. Colorectal Dis. 2012 Oct;14(10):e635-42. doi: 10.1111/j.1463-1318.2012.03104.x. Review.</citation>
    <PMID>22632762</PMID>
  </reference>
  <reference>
    <citation>Neal JM, Brull R, Chan VW, Grant SA, Horn JL, Liu SS, McCartney CJ, Narouze SN, Perlas A, Salinas FV, Sites BD, Tsui BC. The ASRA evidence-based medicine assessment of ultrasound-guided regional anesthesia and pain medicine: Executive summary. Reg Anesth Pain Med. 2010 Mar-Apr;35(2 Suppl):S1-9. doi: 10.1097/AAP.0b013e3181d22fe0. Review. Erratum in: Reg Anesth Pain Med. 2010 May-Jun;35(2):325.</citation>
    <PMID>20216019</PMID>
  </reference>
  <reference>
    <citation>Børglum J, Gögenür I, Bendtsen TF. Abdominal wall blocks in adults. Curr Opin Anaesthesiol. 2016 Oct;29(5):638-43. doi: 10.1097/ACO.0000000000000378. Review.</citation>
    <PMID>27429253</PMID>
  </reference>
  <reference>
    <citation>Keller DS, Madhoun N, Ponte-Moreno OI, Ibarra S, Haas EM. Transversus abdominis plane blocks: pilot of feasibility and the learning curve. J Surg Res. 2016 Jul;204(1):101-8. doi: 10.1016/j.jss.2016.04.012. Epub 2016 Apr 27.</citation>
    <PMID>27451874</PMID>
  </reference>
  <reference>
    <citation>Keller DS, Ermlich BO, Schiltz N, Champagne BJ, Reynolds HL Jr, Stein SL, Delaney CP. The effect of transversus abdominis plane blocks on postoperative pain in laparoscopic colorectal surgery: a prospective, randomized, double-blind trial. Dis Colon Rectum. 2014 Nov;57(11):1290-7. doi: 10.1097/DCR.0000000000000211.</citation>
    <PMID>25285696</PMID>
  </reference>
  <reference>
    <citation>Favuzza J, Brady K, Delaney CP. Transversus abdominis plane blocks and enhanced recovery pathways: making the 23-h hospital stay a realistic goal after laparoscopic colorectal surgery. Surg Endosc. 2013 Jul;27(7):2481-6. doi: 10.1007/s00464-012-2761-y. Epub 2013 Jan 26.</citation>
    <PMID>23355160</PMID>
  </reference>
  <reference>
    <citation>Rafi AN. Abdominal field block: a new approach via the lumbar triangle. Anaesthesia. 2001 Oct;56(10):1024-6.</citation>
    <PMID>11576144</PMID>
  </reference>
  <reference>
    <citation>Hebbard P, Fujiwara Y, Shibata Y, Royse C. Ultrasound-guided transversus abdominis plane (TAP) block. Anaesth Intensive Care. 2007 Aug;35(4):616-7.</citation>
    <PMID>18020088</PMID>
  </reference>
  <reference>
    <citation>Chetwood A, Agrawal S, Hrouda D, Doyle P. Laparoscopic assisted transversus abdominis plane block: a novel insertion technique during laparoscopic nephrectomy. Anaesthesia. 2011 Apr;66(4):317-8. doi: 10.1111/j.1365-2044.2011.06664.x.</citation>
    <PMID>21401554</PMID>
  </reference>
  <reference>
    <citation>Elamin G, Waters PS, Hamid H, O'Keeffe HM, Waldron RM, Duggan M, Khan W, Barry MK, Khan IZ. Efficacy of a Laparoscopically Delivered Transversus Abdominis Plane Block Technique during Elective Laparoscopic Cholecystectomy: A Prospective, Double-Blind Randomized Trial. J Am Coll Surg. 2015 Aug;221(2):335-44. doi: 10.1016/j.jamcollsurg.2015.03.030. Epub 2015 Mar 27.</citation>
    <PMID>25899736</PMID>
  </reference>
  <reference>
    <citation>Park SY, Park JS, Choi GS, Kim HJ, Moon S, Yeo J. Comparison of Analgesic Efficacy of Laparoscope-Assisted and Ultrasound-Guided Transversus Abdominis Plane Block after Laparoscopic Colorectal Operation: A Randomized, Single-Blind, Non-Inferiority Trial. J Am Coll Surg. 2017 Sep;225(3):403-410. doi: 10.1016/j.jamcollsurg.2017.05.017. Epub 2017 Jun 10.</citation>
    <PMID>28610880</PMID>
  </reference>
  <reference>
    <citation>Zaghiyan KN, Mendelson BJ, Eng MR, Ovsepyan G, Mirocha JM, Fleshner P. Randomized Clinical Trial Comparing Laparoscopic Versus Ultrasound-Guided Transversus Abdominis Plane Block in Minimally Invasive Colorectal Surgery. Dis Colon Rectum. 2019 Feb;62(2):203-210. doi: 10.1097/DCR.0000000000001292.</citation>
    <PMID>30540660</PMID>
  </reference>
  <reference>
    <citation>Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b.</citation>
    <PMID>23411725</PMID>
  </reference>
  <reference>
    <citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.</citation>
    <PMID>15273542</PMID>
  </reference>
  <reference>
    <citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70.</citation>
    <PMID>6880820</PMID>
  </reference>
  <reference>
    <citation>Dickerson DM, Apfelbaum JL. Local anesthetic systemic toxicity. Aesthet Surg J. 2014 Sep;34(7):1111-9. doi: 10.1177/1090820X14543102. Epub 2014 Jul 15. Review.</citation>
    <PMID>25028740</PMID>
  </reference>
  <reference>
    <citation>Naidu RK, Richebe P. Probable local anesthetic systemic toxicity in a postpartum patient with acute Fatty liver of pregnancy after a transversus abdominis plane block. A A Case Rep. 2013 Dec 1;1(5):72-4. doi: 10.1097/ACC.0b013e3182973a2f.</citation>
    <PMID>25612087</PMID>
  </reference>
  <reference>
    <citation>Statzer N, Cummings KC 3rd. Transversus Abdominis Plane Blocks. Adv Anesth. 2018 Dec;36(1):163-180. doi: 10.1016/j.aan.2018.07.007. Epub 2018 Sep 27. Review.</citation>
    <PMID>30414636</PMID>
  </reference>
  <reference>
    <citation>Chin KJ, McDonnell JG, Carvalho B, Sharkey A, Pawa A, Gadsden J. Essentials of Our Current Understanding: Abdominal Wall Blocks. Reg Anesth Pain Med. 2017 Mar/Apr;42(2):133-183. doi: 10.1097/AAP.0000000000000545. Review.</citation>
    <PMID>28085788</PMID>
  </reference>
  <reference>
    <citation>Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995; 7: 524.</citation>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 9, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>June 17, 2020</last_update_submitted>
  <last_update_submitted_qc>June 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nordsjaellands Hospital</investigator_affiliation>
    <investigator_full_name>Claus Anders Bertelsen, PhD, MD</investigator_full_name>
    <investigator_title>Associate professor, consultant surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After de-identification, individual participant data will be made available to investigators who provide a methodologically sound proposal for meta-analyses. Proposals should be directed to Claus A Bertelsen (cabertelsen@gmail.com). A Data Processing Agreement according to the EU General Data Protection Regulation has to be signed before data sharing.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>For 15 years after publication</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

